NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $10,451,000 | -14.9% | 115,000 | -30.3% | 2.22% | -13.1% |
Q2 2017 | $12,281,000 | +87.8% | 165,000 | +83.3% | 2.55% | +62.2% |
Q4 2016 | $6,539,000 | +4.4% | 90,000 | +50.0% | 1.57% | +54.9% |
Q3 2016 | $6,263,000 | +6.1% | 60,000 | -25.0% | 1.02% | -40.4% |
Q2 2016 | $5,901,000 | +39.8% | 80,000 | +6.7% | 1.70% | -28.6% |
Q1 2016 | $4,220,000 | -26.5% | 75,000 | -11.8% | 2.39% | +1.7% |
Q4 2015 | $5,738,000 | +29.0% | 85,000 | -26.1% | 2.35% | +10.1% |
Q4 2014 | $4,447,000 | – | 115,000 | – | 2.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |